Learn about ongoing and upcoming clinical studies at Ayutara.
Advancing precision medicine through rigorous, ethical, and innovative research in oncology, neurology, and rare diseases.
First-in-human studies to evaluate safety and optimal dosing.
Assess therapeutic effect in targeted patient population.
Large-scale trials to confirm efficacy and monitor side effects.
Long-term safety and real-world effectiveness monitoring.
Novel tau protein inhibitor for early-stage Alzheimer's. Recruiting.
Gene therapy for Hemophilia B. Active, not recruiting.
CAR-T cell therapy for relapsed lymphoma. First cohort completed.
Join a clinical trial and help shape the future of medicine.